Javascript must be enabled to continue!
Abstract IA11: The War on Melanoma: Oregon’s early detection experiment
View through CrossRef
Abstract
Early detection of melanoma has several advantages over treatment of late-stage disease. Cure rates are higher, disfigurement is reduced, both short-term and long-term side effects from unnecessary systemic therapies are avoided, and most importantly, a large number of lives of individuals who would never have responded to these treatments in the first place are saved. Early detection is also likely to reduce the overall cost of care because early-stage treatments are far less expensive than those used in advanced disease. Despite the potential benefits of screening and early detection, relatively few prospective interventional studies have been performed to objectively demonstrate effectiveness or quantify the effects. However, multivariate data do show that a basic awareness of skin health and appearance (not requiring specialized knowledge of melanoma features) is associated with early detection of melanoma. The purpose of the War on Melanoma research study is to prospectively test whether a statewide early-detection campaign can improve melanoma outcomes. We will compare three objective metrics before and after the intervention (the education campaign): (1) melanoma knowledge in the general public by survey of a representative population sample; (2) state cancer registry data on stage, mortality, etc.; and (3) cost information from an all-claims, all-payers database. We hypothesize that there will be an increase in melanoma-specific knowledge in the general public, an improved prognosis at the time of diagnosis, and a decrease in melanoma mortality in Oregon compared to two control states (Utah and Washington). We will also quantify the difference in cost of care for melanoma before and after the campaign and will determine if these costs are associated with knowledge levels and/or prognostic/mortality data. These results will provide a model for future early-detection campaigns in other states or for other cancers, by providing evidence for the impact of public health education.
Citation Format: Sancy A. Leachman, Jodi Lapidus, Kemal Sonmez, Michael Heath, Brian Detweiler-Bedell, Jerusha Detweiler-Bedell, Elizabeth G. Berry, Elizabeth Stoos. The War on Melanoma: Oregon’s early detection experiment [abstract]. In: Proceedings of the AACR Special Conference on Melanoma: From Biology to Target; 2019 Jan 15-18; Houston, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(19 Suppl):Abstract nr IA11.
American Association for Cancer Research (AACR)
Title: Abstract IA11: The War on Melanoma: Oregon’s early detection experiment
Description:
Abstract
Early detection of melanoma has several advantages over treatment of late-stage disease.
Cure rates are higher, disfigurement is reduced, both short-term and long-term side effects from unnecessary systemic therapies are avoided, and most importantly, a large number of lives of individuals who would never have responded to these treatments in the first place are saved.
Early detection is also likely to reduce the overall cost of care because early-stage treatments are far less expensive than those used in advanced disease.
Despite the potential benefits of screening and early detection, relatively few prospective interventional studies have been performed to objectively demonstrate effectiveness or quantify the effects.
However, multivariate data do show that a basic awareness of skin health and appearance (not requiring specialized knowledge of melanoma features) is associated with early detection of melanoma.
The purpose of the War on Melanoma research study is to prospectively test whether a statewide early-detection campaign can improve melanoma outcomes.
We will compare three objective metrics before and after the intervention (the education campaign): (1) melanoma knowledge in the general public by survey of a representative population sample; (2) state cancer registry data on stage, mortality, etc.
; and (3) cost information from an all-claims, all-payers database.
We hypothesize that there will be an increase in melanoma-specific knowledge in the general public, an improved prognosis at the time of diagnosis, and a decrease in melanoma mortality in Oregon compared to two control states (Utah and Washington).
We will also quantify the difference in cost of care for melanoma before and after the campaign and will determine if these costs are associated with knowledge levels and/or prognostic/mortality data.
These results will provide a model for future early-detection campaigns in other states or for other cancers, by providing evidence for the impact of public health education.
Citation Format: Sancy A.
Leachman, Jodi Lapidus, Kemal Sonmez, Michael Heath, Brian Detweiler-Bedell, Jerusha Detweiler-Bedell, Elizabeth G.
Berry, Elizabeth Stoos.
The War on Melanoma: Oregon’s early detection experiment [abstract].
In: Proceedings of the AACR Special Conference on Melanoma: From Biology to Target; 2019 Jan 15-18; Houston, TX.
Philadelphia (PA): AACR; Cancer Res 2020;80(19 Suppl):Abstract nr IA11.
Related Results
Abstract LB163: Germline pathogenic variants in melanoma patients
Abstract LB163: Germline pathogenic variants in melanoma patients
Abstract
Background: The etiology of melanoma has generally been thought to be exposure to UV radiation (sun and sun tanning lamps). However, the percent of melanoma...
The Risk of Subsequent Invasive Melanoma after a Primary in Situ or Invasive Melanoma in a High Incidence Country (New Zealand)
The Risk of Subsequent Invasive Melanoma after a Primary in Situ or Invasive Melanoma in a High Incidence Country (New Zealand)
Abstract
Background
Patients with invasive melanoma are at increased risk of developing subsequent invasive melanoma, but the ri...
Divergent pathways of melanoma development: evidence from a Southern European cohort
Divergent pathways of melanoma development: evidence from a Southern European cohort
Nevus counts in the divergent pathway model of melanoma development have been studied mainly in patients in Australia. Our aim was to compare nevus counts and the melanoma subtype ...
Abstract 1297: The heritability of melanoma differs between light- and dark-skinned individuals of European descent
Abstract 1297: The heritability of melanoma differs between light- and dark-skinned individuals of European descent
Abstract
Melanoma is strongly associated with exposure to ultraviolet radiation (UV). The prevalence of melanoma is much higher in lighter-skinned Caucasians as comp...
Genomic and proteomic findings in early melanoma and opportunities for early diagnosis
Genomic and proteomic findings in early melanoma and opportunities for early diagnosis
AbstractOverdiagnosis of early melanoma is a significant problem. Due to subtle unique and overlapping clinical and histological criteria between pigmented lesions and the risk of ...
Precursors of skin melanoma (melanoma-sensitive nevi)
Precursors of skin melanoma (melanoma-sensitive nevi)
Interest in melanoma precursors, or melanoma-sensitive skin nevi, has not lost its relevance for many years due to the steady increase of skin melanoma morbidity in recent decades ...
Abstract 1143: Pro-proliferative function of SIRT3 in a human melanoma xenograft mouse model
Abstract 1143: Pro-proliferative function of SIRT3 in a human melanoma xenograft mouse model
Abstract
Melanoma is one of the most aggressive forms of skin cancer and is often lethal, if not treated early. Therefore, it is necessary to try to develop novel ta...
Pyridinium derivatives for metastatic melanoma therapy
Pyridinium derivatives for metastatic melanoma therapy
<p>Melanoma incidence is increasing faster than any other cancer worldwide.1 Early detection is often curative, but metastatic melanoma is lethal (5-year survival <20%) du...

